Results 11 to 20 of about 66,518 (227)

Ablation of C-type natriuretic peptide/cGMP signaling in fibroblasts exacerbates adverse cardiac remodeling in mice. [PDF]

JCI Insight, 2023
Werner F, Prentki Santos E, Michel K, Schrader H, Völker K, Potapenko T, Krebes L, Abeßer M, Möllmann D, Schlattjan M, Schmidt H, Skryabin BV, Špiranec Spes K, Schuh K, Denton CP, Baba HA, Kuhn M.   +16 more
europepmc   +3 more sources

C-type natriuretic peptide mitigates apoptosis in ovarian granulosa cells through the cGMP pathway independent of PKG signaling. [PDF]

J Ovarian Res
Wei Y, Deng H, Liu Q, Wu Y, An L, Tian J, Xi G.   +6 more
europepmc   +3 more sources

C-type natriuretic peptide improves maternally aged oocytes quality by inhibiting excessive PINK1/Parkin-mediated mitophagy. [PDF]

Elife, 2023
Zhang H, Li C, Liu Q, Li J, Wu H, Xu R, Sun Y, Cheng M, Zhao X, Pan M, Wei Q, Ma B.   +11 more
europepmc   +2 more sources

Effect of C-Type Natriuretic Peptide (CNP) on Spermatozoa Maturation in Adult Rat Epididymis. [PDF]

Curr Issues Mol Biol, 2023
Zhao H, Yu Y, Mei C, Zhang T, Kang Y, Li N, Huang D.   +6 more
europepmc   +3 more sources

Optimizing C-Type Natriuretic Peptide and Receptor Expression Analysis with Droplet Digital™ PCR: Advancing Biomarker Discovery for Brugada Syndrome? [PDF]

Biomolecules
Cabiati M, Vozzi F, Persiani E, Piacenti M, Rossi A, Sgalippa A, Cecchettini A, Solarino G, Zucchelli G, Mazzocchetti L, Notarstefano P, Guiducci L, Morales MA, Del Ry S.   +13 more
europepmc   +3 more sources

Sex-specific mortality prediction by pro-C-type natriuretic peptide measurement in a prospective cohort of patients with ST-elevation myocardial infarction. [PDF]

BMJ Open, 2021
Mark PD, Frydland M, Helgestad OKL, Holmvang L, Møller JE, Johansson PI, Ostrowski SR, Prickett T, Hassager C, Goetze JP.   +9 more
europepmc   +3 more sources

Circulatory C-type natriuretic peptide reduces mucopolysaccharidosis-associated craniofacial hypoplasia in vivo. [PDF]

PLoS One, 2022
Kashiwagi M, Nakao K, Yamanaka S, Yamauchi I, Yamashita T, Fujii T, Ueda Y, Kawai MY, Watanabe T, Fukuhara S, Bessho K.   +10 more
europepmc   +3 more sources

Pathogenetic justification of sacubitril / valsartan use in respiratory-cardial comorbidity

Patologìâ, 2023
Among the comorbid conditions that significantly worsen quality of life and life expectancy are the chronic obstructive pulmonary disease and heart failure.
T. V. Ashcheulova, K. M. Kompaniiets, N. M. Herasymchuk, I. V. Sytina   +3 more
doaj   +1 more source

Natriuretic Peptide-Based Novel Therapeutics: Long Journeys of Drug Developments Optimized for Disease States

Biology, 2022
The field of natriuretic peptides (NPs) as an endocrine hormone has been developing since 1979. There are three peptides in humans: atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP), which bind to the guanylyl cyclase-A (GC-A ...
Tomoko Ichiki, Atsushi Jinno, Yoshihisa Tsuji   +2 more
doaj   +1 more source

Pre-IVM with C-type natriuretic peptide promotes mitochondrial biogenesis of bovine oocytes via activation of CREB. [PDF]

Sci Rep
Zhang Z, Jia Z.
europepmc   +3 more sources